Hellmann, David - Johns Hopkins University

个人简介

Dr. Hellmann is one of Johns Hopkins best physicians, teachers, and program builders. He holds the Aliki Perroti endowed Chair, recognizing his leadership in education. Dr. Hellmann’s clinical care and research focus is on vasculitis. Over the last four years, Dr. Hellmann has evaluated over 200 patients with systemic vasculitis. Areas of interest have included Wegener’s granulomatosis, temporal arteritis, Takayasu’s arteritis, and polyarteritis nodosa. Dr. Hellmann is director of the Johns Hopkins Center for Innovative Medicine which promotes patient-centered care through the creative collaboration of research, teaching, and patient care programs. MD, Johns Hopkins University School of Medicine (1977)

研究领域

Evaluation of patients with Takayasus arteritis and temporal arteritis

近期论文

查看导师最新文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Levine SM, Hellman DB: Giant cell arteritis. Curr Opin Rheumatol. (In Press 2002). Regan MJ, Wood BJ, Hsieh YH, Theodore ML, Quinn TC, Hellman DB, Green WR, Gaydos CA. Stone JH: Chlamydia pneumoniae and Temporal Arteritis: Failure to detect the organism by PCR in 180 cases and controls. Arthritis Rheum (In Press). Stone J, Hellmann DB (eds). Rheumatic Disease Clinics of North America: Vasculitis. Philadelphia, W.B. Saunders, 2001. Scatarige JC, Urban, BA, Hellmann DB, Fishman EK: Threedimensional volumerendering CT angiography in vasculitis: spectrum of disease and clinical utility. J Comput Asst Tomogr 25:598603, 2001. Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs N, Hoffman GS: Etanercept combined with conventional treatment in Wegeners granulomatosis: a six-month openlabel trial to evaluate safety. Arthritis Rheum 44:11491154, 2001.